Altisource Asset Management Corporation ("AAMC" or the "Company") (NYSE:AAMC) announces that it has settled litigation with Luxor Capital Group, LP and related entities (collectively "Luxor") in respect of the Company's
Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.
ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.
As of Dec. 11, 2023, five stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.
Altisource Asset Management Corporation ("AAMC" or the "Company") (NYSE:AAMC) announces that on November 30, 2023, the Company received a written notice (the "Notice") from the New York Stock Exchange ("NYSE" or the
Gainers
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.
Altisource Asset Management Corporation ("AAMC" or the "Company") (NYSE:AAMC) announces that the Board of Directors has elected to cancel the previously reported 2 for 1 common stock split and instead is proceeding with